{
  "schema_version": "2.0",
  "doc_id": "d8bf90471ff5968cbdaefd032cbea28a776f61b6a6aedcbb879a9a1550ef0eab",
  "extracted_at": "2026-02-01T08:08:53.011518+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "PharmEffect",
      "name": "Antidepressant effects",
      "attributes": {
        "context": "Antidepressant effects"
      },
      "source_chunk_ids": [
        "ee3db8415a2944c7f8934cce2f5ae17e"
      ]
    },
    {
      "id": "ent_002",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "inhibitors of cAMP phosphodiesterase"
      },
      "source_chunk_ids": [
        "ee3db8415a2944c7f8934cce2f5ae17e"
      ]
    },
    {
      "id": "ent_003",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "phosphodiesterase (PDE4)"
      },
      "source_chunk_ids": [
        "ee3db8415a2944c7f8934cce2f5ae17e"
      ]
    },
    {
      "id": "ent_004",
      "type": "Compound",
      "name": "type 4 phosphodiesterase (PDE4) inhibitors",
      "attributes": {
        "context": "development of type 4 phosphodiesterase (PDE4) inhibitors"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_005",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "inhibitors as antidepressants"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_006",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "importance of PDE4 subtypes"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_007",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "potential of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_008",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PDE4 has been shown to be involved"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_009",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "involved in cAMP signaling pathways"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_010",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "affected by antidepressants"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_011",
      "type": "Compound",
      "name": "PDE4D",
      "attributes": {
        "context": "that PDE4D and PDE4B mediate"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_012",
      "type": "Compound",
      "name": "PDE4B",
      "attributes": {
        "context": "PDE4D and PDE4B mediate antidepressant effects"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_013",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "mediate antidepressant effects"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_014",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "conformer of PDE4 is particularly important"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_015",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "important for antidepressant efficacy"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_016",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "actions of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ]
    },
    {
      "id": "ent_017",
      "type": "Compound",
      "name": "PDE4D",
      "attributes": {
        "context": "PDE4D has been shown to be regulated"
      },
      "source_chunk_ids": [
        "aa5fb0e435cad9df2e58b5707ff754ae"
      ]
    },
    {
      "id": "ent_018",
      "type": "PharmEffect",
      "name": "regulation",
      "attributes": {
        "context": "of regulation in the brain"
      },
      "source_chunk_ids": [
        "aa5fb0e435cad9df2e58b5707ff754ae"
      ]
    },
    {
      "id": "ent_019",
      "type": "PharmEffect",
      "name": "regulated at the expression level",
      "attributes": {
        "context": "regulated at the expression level in several cell types"
      },
      "source_chunk_ids": [
        "aa5fb0e435cad9df2e58b5707ff754ae"
      ]
    },
    {
      "id": "ent_020",
      "type": "PharmEffect",
      "name": "antidepressant actions",
      "attributes": {
        "context": "implicated in antidepressant actions"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_021",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "involves PDE4"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_022",
      "type": "Compound",
      "name": "NMDA-receptor",
      "attributes": {
        "context": "NMDA-receptor-mediated signaling"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_023",
      "type": "Compound",
      "name": "NMDA receptors",
      "attributes": {
        "context": "The role of NMDA receptors"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_024",
      "type": "PharmEffect",
      "name": "antidepressant effects",
      "attributes": {
        "context": "mediating antidepressant effects"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_025",
      "type": "Compound",
      "name": "NMDA antagonists",
      "attributes": {
        "context": "NMDA antagonists such as MK801"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_026",
      "type": "Compound",
      "name": "MK801",
      "attributes": {
        "context": "such as MK801 (dizocilpine)"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_027",
      "type": "Compound",
      "name": "dizocilpine",
      "attributes": {
        "context": "MK801 (dizocilpine)"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_028",
      "type": "PharmEffect",
      "name": "antidepressant-like effects",
      "attributes": {
        "context": "produce antidepressant-like effects"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_029",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "rolipram has been shown to reverse memory deficits"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_030",
      "type": "PharmEffect",
      "name": "reverse memory deficits",
      "attributes": {
        "context": "reverse memory deficits that result from dizocilpine treatment"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_031",
      "type": "Compound",
      "name": "dizocilpine",
      "attributes": {
        "context": "result from dizocilpine treatment"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_032",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "role of PDE4 in NMDA-receptor-mediated signaling"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_033",
      "type": "Compound",
      "name": "NMDA-receptor",
      "attributes": {
        "context": "PDE4 in NMDA-receptor-mediated signaling"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_034",
      "type": "PharmEffect",
      "name": "cognitive deficits",
      "attributes": {
        "context": "related more to cognitive deficits"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_035",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "that occur in depression"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_036",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "functional role of PDE4 in NMDA receptor-mediated signaling"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "NMDA receptor",
      "attributes": {
        "context": "PDE4 in NMDA receptor-mediated signaling"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "NMDA receptors",
      "attributes": {
        "context": "Stimulation of NMDA receptors"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_039",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "concentrations of cAMP and cGMP"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_040",
      "type": "Compound",
      "name": "cGMP",
      "attributes": {
        "context": "cAMP and cGMP"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_041",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "the cAMP formed by NMDA-receptor stimulation"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "NMDA-receptor",
      "attributes": {
        "context": "cAMP formed by NMDA-receptor stimulation"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_043",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "hydrolyzed exclusively by PDE4"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_044",
      "type": "Compound",
      "name": "cGMP",
      "attributes": {
        "context": "the cGMP that forms is hydrolyzed by PDE2"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_045",
      "type": "Compound",
      "name": "PDE2",
      "attributes": {
        "context": "hydrolyzed by PDE2 only"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "PDE4 subtypes",
      "attributes": {
        "context": "which PDE4 subtypes are components"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_047",
      "type": "Compound",
      "name": "NMDA-receptor",
      "attributes": {
        "context": "components of NMDA-receptor-mediated signaling"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ]
    },
    {
      "id": "ent_048",
      "type": "PharmEffect",
      "name": "antidepressant-like profile",
      "attributes": {
        "context": "exhibit an antidepressant-like profile"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_049",
      "type": "PharmEffect",
      "name": "reduced immobility",
      "attributes": {
        "context": "evidenced by reduced immobility"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_050",
      "type": "PharmEffect",
      "name": "reduced immobility",
      "attributes": {
        "context": "This reduced immobility is similar"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_051",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "putative antidepressant rolipram"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_052",
      "type": "PharmEffect",
      "name": "reduction in immobility",
      "attributes": {
        "context": "A further reduction in immobility"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_053",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {
        "context": "antidepressants desipramine"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_054",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "and fluoxetine are administered"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_055",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "rolipram causes, at best"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_056",
      "type": "PharmEffect",
      "name": "reduction in the time of immobility",
      "attributes": {
        "context": "additional reduction in the time of immobility"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ]
    },
    {
      "id": "ent_057",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "the ability of rolipram to enhance"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_058",
      "type": "PharmEffect",
      "name": "\\beta-adrenoceptor-mediated cAMP formation",
      "attributes": {
        "context": "enhance \\beta-adrenoceptor-mediated cAMP formation in the cerebral cortex"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_059",
      "type": "Compound",
      "name": "PDE4D",
      "attributes": {
        "context": "diminished in PDE4D-deficient mice"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {
        "context": "effect of desipramine and fluoxetine"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "effect of desipramine and fluoxetine"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "PDE4D",
      "attributes": {
        "context": "that PDE4D is not involved"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_063",
      "type": "Compound",
      "name": "monoamine-uptake inhibitors",
      "attributes": {
        "context": "If the monoamine-uptake inhibitors produce their effects"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_064",
      "type": "PharmEffect",
      "name": "receptor-mediated cAMP formation",
      "attributes": {
        "context": "by increasing receptor-mediated cAMP formation"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_065",
      "type": "Compound",
      "name": "PDE4 subtype",
      "attributes": {
        "context": "loss of the PDE4 subtype in the affected pathway"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_066",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {
        "context": "enhance the effects of desipramine and fluoxetine"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_067",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "enhance the effects of desipramine and fluoxetine"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ]
    },
    {
      "id": "ent_068",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {
        "context": "treatment with either desipramine or fluoxetine"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_069",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "desipramine or fluoxetine, antidepressants"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_070",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "antidepressants that exert their antidepressant effects"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_071",
      "type": "PharmEffect",
      "name": "antidepressant effects",
      "attributes": {
        "context": "exert their antidepressant effects primarily"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_072",
      "type": "Compound",
      "name": "noradrenaline",
      "attributes": {
        "context": "via noradrenaline-mediated and 5-HT-mediated actions"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {
        "context": "noradrenaline-mediated and 5-HT-mediated actions"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_074",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "increase in PDE4 expression"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_075",
      "type": "PharmEffect",
      "name": "antidepressants",
      "attributes": {
        "context": "indicates that the antidepressants alter components"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_076",
      "type": "PharmEffect",
      "name": "antidepressant effects",
      "attributes": {
        "context": "these antidepressant effects are secondary"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ]
    },
    {
      "id": "ent_077",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {
        "context": "ability of desipramine"
      },
      "source_chunk_ids": [
        "b933b9ca948b4f2dc96ff4520056b739"
      ]
    },
    {
      "id": "ent_078",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "and fluoxetine to increase"
      },
      "source_chunk_ids": [
        "b933b9ca948b4f2dc96ff4520056b739"
      ]
    },
    {
      "id": "ent_079",
      "type": "Indication",
      "name": "lesion",
      "attributes": {
        "context": "lesion of these systems"
      },
      "source_chunk_ids": [
        "b933b9ca948b4f2dc96ff4520056b739"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:03.750736+00:00",
    "original_file": "entities.json"
  }
}